BALYASNY ASSET MANAGEMENT L.P. - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$14,538,000
+3130.7%
313,796
+893.7%
0.09%
+3000.0%
Q4 2018$450,000
-95.0%
31,579
-94.7%
0.00%
-92.7%
Q3 2018$8,975,000
+1298.0%
595,888
+1458.0%
0.04%
+1266.7%
Q2 2018$642,000
-87.6%
38,248
-88.0%
0.00%
-86.4%
Q1 2018$5,183,000
-77.8%
317,608
-82.6%
0.02%
-69.9%
Q4 2017$23,332,000
+452.1%
1,822,804
+430.6%
0.07%
+329.4%
Q3 2017$4,226,000
-29.8%
343,559
-52.2%
0.02%
-32.0%
Q2 2017$6,019,000
-7.6%
719,124
-1.4%
0.02%
-19.4%
Q1 2017$6,517,000
-46.7%
729,000
-47.5%
0.03%
-53.0%
Q4 2016$12,216,000
+10615.8%
1,389,775
+4230.9%
0.07%
+6500.0%
Q2 2016$114,000
-22.4%
32,090
-35.5%
0.00%0.0%
Q1 2016$147,000
-27.9%
49,790
+3.0%
0.00%0.0%
Q4 2015$204,000
-36.4%
48,360
-31.4%
0.00%
-50.0%
Q3 2015$321,000
-39.2%
70,450
-3.7%
0.00%
-33.3%
Q2 2015$528,000
-94.6%
73,190
-96.5%
0.00%
-97.3%
Q1 2014$9,732,000
+61.6%
2,070,626
+72.2%
0.11%
+42.3%
Q4 2013$6,023,000
-13.0%
1,202,200
+8.0%
0.08%
-16.1%
Q3 2013$6,921,000
+173.2%
1,112,684
+99.4%
0.09%
+116.3%
Q2 2013$2,533,000557,9400.04%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders